Thalidomide plus prednisone with or without danazol therapy in myelofibrosis: a retrospective analysis of incidence and durability of anemia response

Low-dose thalidomide and prednisone alone or combined are effective therapies in some persons with primary myelofibrosis (PMF) and anemia with or with RBC transfusion dependence. Danazol is also effective in some persons with PMF and anemia. Responses to these drugs are typically incomplete and not...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Xueping, Xu, Zefeng, Li, Bing, Qin, Tiejun, Zhang, Peihong, Zhang, Hongli, Fang, Liwei, Pan, Lijuan, Hu, Naibo, Qu, Shiqiang, Zhang, Yue, Huang, Gang, Peter Gale, Robert, Xiao, Zhijian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802625/
https://www.ncbi.nlm.nih.gov/pubmed/29335406
http://dx.doi.org/10.1038/s41408-017-0029-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802625/
https://www.ncbi.nlm.nih.gov/pubmed/29335406
http://dx.doi.org/10.1038/s41408-017-0029-4

Ejemplares similares